Are ICU Medical & GE HealthCare Competing to Acquire 2 Units from Medtronic?

The two companies could be in the running to acquire Medtronic’s patient monitoring and intervention businesses, according to a report from Reuters.

Omar Ford

March 29, 2023

2 Min Read
IMG_2023-3-29-145530.jpg
Image Credit: Just Super/ iStock via Getty Images

GE HealthCare is facing some competition from ICU Medical in the pursuit to acquire two units being divested by Medtronic, according to a report from Reuters

The medtech giant is seeking to sell its patient monitoring and respiratory intervention units for a price between $8 billion and $9 billion, Reuters reported citing people familiar with the process.

Dublin-based Medtronic has been taking offers for the unit even though it is in preparations to spin off the businesses, according to the Reuters report. ICU Medical has submitted an offer for the assets in partnership with a buyout firm Linden Capital Partners, according to sources cited in the Reuters report.

Medtronic first announced it was spinning off the units in October of last year. GE HealthCare is actually the product of a successful spinoff. It was announced the company would separate from General Electric in 2021. The separation was completed in January.

GE HealthCare kicked off 2023 with M&A. The company first proposed a deal to acquire Imactis,  a French CT interventional guidance technology developer. Financial details were scant, however, GE HealthCare said it would fund the transaction with cash on hand.

In February, GE HealthCare would go on to sign an agreement to acquire Caption Health, a private company that specializes in using artificial intelligence to assist in conducting ultrasound scans.

The report from Reuters comes on the heels of Medtronic announcing it would offer early retirement incentives to employees as it seeks to cut costs before the end of its fiscal year next month. 

The company also announced the pricing of $2 billion of its senior notes. The firm said the net proceeds of the offering are expected to be used to repay indebtedness, which is expected to include a portion of the outstanding indebtedness under Medtronic Luxco's Japanese-yen-denominated term loan agreement.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like